Companies are developing myostatin inhibitors for GLP-1RA- related muscle loss, but some experts doubt their necessity.

“The weight loss we see [with myostatin inhibitors] is not close to what we’ve seen with GLP-1 therapies,” says Papamargaritis. He lists the study of Eli Lilly’s anti-myostatin drug bimagrumab as an ...

Biohaven will use the money to bankroll commercial preparations for the spinocerebellar ataxia drug candidate troriluzole, ...

Myostatin inhibitors meanwhile have had a patchy history in drug development to date. Early experiments with these drugs suggested that while they can increase muscle mass, that may not lead to ...

KER-065 is designed to block the activity of myostatin and activin A, two proteins that help to regulate muscle growth. In animal models, blocking these proteins has been shown to increase muscle mass ...

The prospects of a new class of Duchenne muscular dystrophy therapies have taken another downturn after Roche abandoned development of RG6206, a myostatin inhibitor. The Swiss group revealed the ...

Unexpected bacterial blocker: Antisense molecules inhibit oral Fusobacterium species linked to cancer progression by Charlotte Schwenner, Helmholtz Association of German Research Centres ...

Jenner & Block asked a judge to permanently block the order, saying it was illegally targeted. The Justice Department lawyer struggled to come up with legal rationales at a Monday hearing.